Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Research Reports

    Kidney Dialysis Equipment and Supplies Market to Reach USD 39.6 Billion by 2035, Growing at 5.0% CAGR

    Kidney Dialysis Equipment and Supplies Market to Reach USD 39.6 Billion by 2035, Growing at 5.0% CAGR

    Published by Wanda Rich

    Posted on April 25, 2025

    Featured image for article about Research Reports

    Analysis of Kidney Dialysis Equipment and Supplies Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

    The global kidney dialysis equipment and supplies market is projected to be valued at USD 24.3 billion in 2025. According to Fact.MR, the market is expected to grow at a compound annual growth rate (CAGR) of 5.0%, reaching a valuation of USD 39.6 billion by 2035.

    In 2024, the industry maintained its steady upward trajectory, largely driven by the rising prevalence of chronic kidney disease (CKD) and the growing demand for cost-effective renal care solutions.

    One of the most notable developments was the increasing preference among patients for home-based dialysis treatments—a trend amplified by the post-pandemic shift toward decentralized healthcare systems. This transition was further supported by advancements in technology, particularly in wearable and portable dialysis devices, which gained significant traction across both developed and emerging healthcare markets.

    As the industry moves into 2025, it stands poised for accelerated growth. Global health systems are intensifying their adoption of next-generation dialysis technologies. Ongoing clinical trials and regulatory approvals are set to bring a wave of intelligent, AI-powered dialysis machines to the market—enabling more personalized treatment plans and enhancing patient adherence.

    For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7599

    Strategic investments in developing regions, especially across Asia and Latin America, are expected to broaden market reach. These initiatives will be propelled by rising awareness of kidney health, improved reimbursement frameworks, and the geographic expansion of dialysis centers, reinforcing the industry's global footprint.

    Market Overview

    CKD affects millions globally, with factors such as hypertension, diabetes, and aging populations contributing to its rising incidence. As the disease progresses to end-stage renal disease (ESRD), dialysis becomes essential for patient survival. This increasing demand for dialysis services is a primary driver of the market.​

    The market encompasses various dialysis modalities, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy (CRRT). Hemodialysis remains the most widely used method, accounting for a significant share of the market due to its established infrastructure and widespread adoption in clinical settings. However, peritoneal dialysis is gaining traction, particularly for home-based treatments, owing to its convenience and cost-effectiveness. ​

    Technological Advancements

    Technological innovations are transforming the dialysis landscape. The development of portable and wearable dialysis machines has enabled patients to undergo treatment in the comfort of their homes, improving quality of life and reducing the burden on healthcare facilities. These advancements are particularly beneficial in remote or underserved areas where access to dialysis centers may be limited.​

    Artificial intelligence (AI) and machine learning are being integrated into dialysis equipment to monitor patient health in real-time, predict complications, and personalize treatment plans. Such technologies enhance patient outcomes and streamline clinical workflows.

    Regional Insights

    North America holds a significant share of the kidney dialysis equipment and supplies market, attributed to the high prevalence of CKD, advanced healthcare infrastructure, and favorable reimbursement policies. The United States alone accounted for approximately USD 5 billion of the market in 2022. ​

    Asia-Pacific is the fastest-growing region, driven by increasing awareness of kidney health, rising healthcare expenditure, and a growing elderly population. China, in particular, is projected to reach a market size of USD 3 billion by 2026, growing at a CAGR of 7%. ​

    Challenges and Opportunities

    Despite the positive outlook, the market faces challenges such as high treatment costs, limited access to dialysis services in low-income regions, and a shortage of trained healthcare professionals. Addressing these issues requires concerted efforts from governments, healthcare providers, and industry stakeholders.​

    Opportunities lie in expanding home-based dialysis programs, investing in telehealth solutions, and developing cost-effective equipment tailored to the needs of emerging markets. Collaborations between public and private sectors can facilitate the establishment of dialysis centers and training programs, improving access to care.​

    Competitive Landscape

    The market is characterized by the presence of several key players, including Fresenius Medical Care, Baxter International, B. Braun Melsungen AG, and Nipro Corporation. These companies are focusing on research and development, strategic partnerships, and mergers and acquisitions to strengthen their market position. ​

    For instance, Fresenius Medical Care has invested in developing advanced dialysis machines and expanding its global footprint through acquisitions and joint ventures. Such initiatives aim to enhance product offerings and cater to the evolving needs of patients and healthcare providers.​

    Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=7599

    Future Outlook

    The kidney dialysis equipment and supplies market is expected to continue its growth trajectory, reaching USD 39.6 billion by 2035. Factors such as the increasing burden of CKD, technological advancements, and a focus on patient-centric care models will drive this expansion.

    Emphasis on preventive care, early diagnosis, and personalized treatment plans will be crucial in managing CKD effectively. Moreover, fostering innovation and ensuring equitable access to dialysis services will be key to addressing the global challenge of kidney disease.

    Explore More Related Studies Published by Fact.MR Research:

    The global cell-free protein expression market is all set to reach a value of US$ 374.5 million in 2024 and has been analyzed to further expand at a CAGR of 7.6% to end up at US$ 780.7 million by 2034.

    The global smart inhaler market is expected to be worth US$ 105.3 million in 2024 and climb to a size of US$ 331 million by the end of 2034. Worldwide sales of smart inhalers are forecasted to increase at a CAGR of 12.1% from 2024 to 2034.

    Revenue from private healthcare services in the United Kingdom is calculated at US$ 14.22 billion for 2024. The United Kingdom market is foreseen to register a CAGR of 2.9% and reach a value of US$ 18.74 billion by the end of 2034.

    Advancements in biomedical technology and a greater focus on precision and visualization in dental procedures are transforming the dental surgery landscape. The global surgical dental loupe and camera market is estimated at US$ 625.9 million in 2024 and is projected to reach US$ 1.52 billion by the end of 2034, expanding at a CAGR of 9.3%

    The global temporary cardiac pacing wire and lead market size is set to reach a value of US$ 364.8 million in 2024 and increase to a size of US$ 683.5 million by the end of 2034. The market has been studied in detail and is forecasted to expand at 6.5% CAGR from 2024 to 2034.

    The global polycystic ovary syndrome (PCOS) treatment market size is set to stand at a value of US$ 4.33 billion in 2024 and further expand at a CAGR of 4.7% to reach US$ 6.84 billion by the end of 2034.

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe